LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) just unveiled an announcement.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced an upcoming board meeting scheduled for March 28, 2025. The meeting’s agenda includes reviewing and approving the company’s annual financial results for the year ending December 31, 2024, and considering the recommendation for a final dividend payment. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates within the medical technology industry, focusing on the development and provision of medical products and services.
YTD Price Performance: 4.59%
Average Trading Volume: 288,430
Technical Sentiment Consensus Rating: Hold
See more insights into 2291 stock on TipRanks’ Stock Analysis page.